ArticleBMC infectious diseases2017
Modular programming for tuberculosis control, the "AuTuMN" platform.
Article in BMC infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Tabby2: a user-friendly web tool for forecasting state-level TB outcomes in the United States.BMC medicine · 2023Article
- COVID-19 collaborative modelling for policy response in the Philippines, Malaysia and Vietnam.The Lancet regional health. Western Pacific · 2022Review
- Estimating the long-term effects of mass screening for latent and active tuberculosis in the Marshall Islands.International journal of epidemiology · 2022Article
- A Web-Based Application to Monitor and Inform about the COVID-19 Outbreak in Italy: The {COVID-19ita} Initiative.Healthcare (Basel, Switzerland) · 2022Article
- Estimating tuberculosis drug resistance amplification rates in high-burden settings.BMC infectious diseases · 2022Article
- Optima TB: A tool to help optimally allocate tuberculosis spending.PLoS computational biology · 2021Article
- Analysis of COVID-19 using a modified SLIR model with nonlinear incidence.Results in physics · 2021Article
- Scenario analysis for programmatic tuberculosis control in Bangladesh: a mathematical modelling study.Scientific reports · 2021Article
- Modelling the Transmission Dynamics of COVID-19 in Six High-Burden Countries.BioMed research international · 2021Article
- Strategic investment in tuberculosis control in the Republic of Bulgaria.Epidemiology and infection · 2019Article
- Strategic Planning for Tuberculosis Control in the Republic of Fiji.Tropical medicine and infectious disease · 2019Article
- Simple Inclusion of Complex Diagnostic Algorithms in Infectious Disease Models for Economic Evaluation.Medical decision making : an international journal of the Society for Medical Decision Making · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTuberculosis (TB) is now the world's leading infectious killer and major programmatic advances will be needed if we are to meet the ambitious new End TB Targets. Although mathematical models are powerful tools for TB control, such models must be flexible enough to capture the complexity and heterogeneity of the global TB epidemic. This includes simulating a disease that affects age groups and other risk groups differently, has varying levels of infectiousness depending upon the organ involved and varying outcomes from treatment depending on the drug resistance pattern of the infecting strain.
resultsWe adopted sound basic principles of software engineering to develop a modular software platform for simulation of TB control interventions ("AuTuMN"). These included object-oriented programming, logical linkage between modules and consistency of code syntax and variable naming. The underlying transmission dynamic model incorporates optional stratification by age, risk group, strain and organ involvement, while our approach to simulating time-variant programmatic parameters better captures the historical progression of the epidemic. An economic model is overlaid upon this epidemiological model which facilitates comparison between new and existing technologies. A "Model runner" module allows for predictions of future disease burden trajectories under alternative scenario situations, as well as uncertainty, automatic calibration, cost-effectiveness and optimisation. The model has now been used to guide TB control strategies across a range of settings and countries, with our modular approach enabling repeated application of the tool without the need for extensive modification for each application.
conclusionsThe modular construction of the platform minimises errors, enhances readability and collaboration between multiple programmers and enables rapid adaptation to answer questions in a broad range of contexts without the need for extensive re-programming. Such features are particularly important in simulating an epidemic as complex and diverse as TB.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.